Hepatitis

The Pharmacy Times® Hepatitis Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of a group of distinct diseases that cause inflammation of the liver, including hepatitis A, B, C, and D.

Latest News

Hepatitis B virus on a white background. 3d illustration | Image Credit: sveta - stock.adobe.com
FDA Approves Expanded Indication for Tenofovir Alafenamide as Hepatitis B Treatment

March 28th 2024

The new indication includes pediatric patients aged 6 years and older who weigh at least 25 kg and have compensated liver disease.

Survodutide Improves Liver Disease Progression in More than 80% of Patients with MASH
Survodutide Improves Liver Disease Progression in More than 80% of Patients with MASH

February 27th 2024

Eliminating Hepatitis C Virus Infections in Individuals who Inject Drugs: A Novel Model of Community Pharmacy Care
Eliminating Hepatitis C Virus Infections in Individuals who Inject Drugs: A Novel Model of Community Pharmacy Care

February 14th 2024

Structural detail of Hepatitis B virus on blue-green background. 3D illustration | Image Credit: Destina - stock.adobe.com
FDA Grants Fast Track Designation to Bepirovirsen for Chronic Hepatitis B

February 12th 2024

Macro of oxycodone opioid tablets | Image Credit: steheap - stock.adobe.com
Telemedicine Shows Increase in Curing Hepatitis C Virus Related to Opioid Use Disorder

November 20th 2023

More News

© 2024 MJH Life Sciences

All rights reserved.